Critical Care

official impact factor 4.60
Search for
Advanced search
Critical Care
Tools
Open Access Highly Access Email this article to a friend

Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective

Jean-Louis Vincent*, Rolf Rossaint, Bruno Riou, Yves Ozier, David Zideman and Donat R Spahn

Critical Care 2006, 10:R120 doi:10.1186/cc5026

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.